61/100B51.365
USD
-0.33
(-0.64%)
Market Closed
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Genmab A operating income 2002–2026What are gross, operating and net profit margins? A profit margin is the share of revenue kept as profit: gross margin after the cost of sales, operating margin after running costs, net margin after all costs.
Genmab A/S ADS's operating income in Q3 FY2026, the three months to 30 September 2026, was 441.00M USD, down 3.9% on the same quarter a year before. Genmab A/S ADS's operating income over the last twelve months was 1.32B USD, down 56.2% on the twelve months before. In fiscal year 2025 it was 1.25B USD, down 81.3% on the year before.
Last updated 8 Nov 2026 · Next report 16 Feb 2027
Operating income
Operating income · +5.5% a year over 10 yearsOperating margin
Growth
| Fiscal year | Period ending | Operating income | Growth | Operating margin | Gross profit | Gross margin | EBITDA |
|---|---|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 1.32B | -56.23% | 30.63% | 3.98B | 92.60% | 1.21B |
| FY2025 | 31 Dec 2025 | 1.25B | -81.34% | 33.60% | 3.41B | 91.69% | 1.34B |
| FY2024 | 31 Dec 2024 | 6.70B | +25.97% | 31.14% | 20.54B | 95.42% | 9.70B |
| FY2023 | 31 Dec 2023 | 5.32B | -15.09% | 32.30% | 16.25B | 98.63% | 6.00B |
| FY2022 | 31 Dec 2022 | 6.27B | +112.22% | 43.21% | 14.51B | 100.00% | 7.35B |
| FY2021 | 31 Dec 2021 | 2.95B | -53.22% | 35.08% | 8.42B | 100.00% | 4.18B |
| FY2020 | 31 Dec 2020 | 6.31B | +139.31% | 62.44% | 10.11B | 100.00% | 6.17B |
| FY2019 | 31 Dec 2019 | 2.64B | +91.12% | 49.16% | 5.37B | 100.00% | 3.01B |
| FY2018 | 31 Dec 2018 | 1.38B | +2.69% | 45.63% | 3.03B | 100.00% | 1.70B |
| FY2017 | 31 Dec 2017 | 1.34B | +27.67% | 56.83% | 2.37B | 100.00% | 1.44B |
| FY2016 | 31 Dec 2016 | 1.05B | +44.15% | 57.97% | 1.82B | 100.00% | 1.17B |
| FY2015 | 31 Dec 2015 | 730.38M | +175.43% | 64.46% | 1.13B | 100.00% | 789.47M |
| FY2014 | 31 Dec 2014 | 265.18M | +282.91% | 31.18% | 850.39M | 100.00% | 313.73M |
| FY2013 | 31 Dec 2013 | 69.25M | — | 10.44% | 663.57M | 100.00% | 80.92M |
| FY2012 | 31 Dec 2012 | -116.68M | — | -24.08% | 484.64M | 100.00% | -96.25M |
| FY2011 | 31 Dec 2011 | -249.42M | — | -71.07% | -181.57M | -51.74% | -192.75M |
| FY2010 | 31 Dec 2010 | -160.69M | — | -27.61% | -435.00K | -0.07% | -61.76M |
| FY2009 | 31 Dec 2009 | -498.03M | — | -84.98% | 586.08M | 100.00% | -77.11M |
| FY2008 | 31 Dec 2008 | -728.49M | — | -105.23% | 696.30M | 100.58% | -516.46M |
| FY2007 | 31 Dec 2007 | -437.13M | — | -82.55% | 529.54M | 100.00% | -317.72M |
| FY2006 | 31 Dec 2006 | -472.21M | — | -348.38% | 135.55M | 100.00% | -419.70M |
| FY2005 | 31 Dec 2005 | -427.92M | -196.97% | -434.42% | 98.51M | 100.00% | -360.46M |
| FY2004 | 31 Dec 2004 | 441.27M | +28.95% | 10,760.13% | 4.10M | 100.00% | 537.46M |
| FY2003 | 31 Dec 2003 | 342.21M | — | 500.85% | 68.33M | 100.00% | 474.56M |
| FY2002 | 31 Dec 2002 | -483.08M | — | — | 0.00 | — | 669.75M |
| Quarter | Period ending | Operating income | Growth on a year before | Operating margin | Gross profit | Gross margin | EBITDA |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 441.00M | -3.92% | 37.15% | 1.10B | 92.59% | 492.00M |
| Q2 FY2026 | 30 Jun 2026 | 407.00M | +13.08% | 35.24% | 1.07B | 92.73% | 431.00M |
| Q1 FY2026 | 31 Mar 2026 | 225.83M | +716.17% | 25.11% | 834.08M | 92.75% | 186.69M |
| Q4 FY2025 | 31 Dec 2025 | 242.27M | -88.78% | 22.97% | 974.05M | 92.34% | 98.70M |
| Q3 FY2025 | 30 Sept 2025 | 459.00M | -78.16% | 44.91% | 964.00M | 94.32% | 503.00M |
| Q2 FY2025 | 30 Jun 2025 | 359.92M | -78.05% | 38.92% | 867.82M | 93.84% | 447.91M |
| Q1 FY2025 | 31 Mar 2025 | 27.67M | -76.15% | 26.29% | 99.05M | 94.13% | 38.90M |
| Q4 FY2024 | 31 Dec 2024 | 2.16B | +29.34% | 33.54% | 6.10B | 94.77% | 2.28B |
| Q3 FY2024 | 30 Sept 2024 | 2.10B | +24.75% | 37.94% | 5.27B | 95.07% | 2.23B |
| Q2 FY2024 | 30 Jun 2024 | 1.64B | +11.72% | 30.36% | 751.00M | 13.90% | 324.00M |
| Q1 FY2024 | 31 Mar 2024 | 116.00M | -72.18% | 19.24% | 576.00M | 95.52% | 266.00M |
| Q4 FY2023 | 31 Dec 2023 | 1.67B | -35.15% | 35.70% | 4.55B | 97.31% | 990.00M |
| Q3 FY2023 | 30 Sept 2023 | 1.69B | -12.74% | 35.76% | 4.63B | 98.32% | 2.76B |
| Q2 FY2023 | 30 Jun 2023 | 1.47B | +17.72% | 35.21% | 4.15B | 99.50% | 1.83B |
| Q1 FY2023 | 31 Mar 2023 | 417.00M | -18.87% | 14.71% | 2.83B | 100.00% | 293.00M |
| Q4 FY2022 | 31 Dec 2022 | 2.58B | +218.29% | 50.13% | 5.14B | 100.00% | 2.78B |
| Q3 FY2022 | 30 Sept 2022 | 1.93B | +116.97% | 47.25% | 4.09B | 100.00% | 3.30B |
| Q2 FY2022 | 30 Jun 2022 | 1.25B | +58.45% | 39.44% | 3.16B | 100.00% | 2.51B |
| Q1 FY2022 | 31 Mar 2022 | 514.00M | -3.38% | 24.26% | 2.12B | 100.00% | 631.00M |
| Q4 FY2021 | 31 Dec 2021 | 809.00M | -8.79% | 30.89% | 2.62B | 100.00% | 1.23B |
| Q3 FY2021 | 30 Sept 2021 | 890.00M | +3.73% | 38.53% | 2.31B | 100.00% | 1.19B |
| Q2 FY2021 | 30 Jun 2021 | 787.00M | -82.50% | 39.91% | 1.97B | 100.00% | 867.00M |
| Q1 FY2021 | 31 Mar 2021 | 532.00M | +649.30% | 33.65% | 1.58B | 100.00% | 1.44B |
| Q4 FY2020 | 31 Dec 2020 | 887.00M | -59.24% | 43.40% | 2.04B | 100.00% | 565.10M |
| Q3 FY2020 | 30 Sept 2020 | 858.00M | +144.44% | 49.77% | 1.72B | 100.00% | 1.40B |
| Q2 FY2020 | 30 Jun 2020 | 4.50B | +3,178.49% | 82.50% | 5.45B | 100.00% | 4.51B |
| Q1 FY2020 | 31 Mar 2020 | 71.00M | — | 7.96% | 892.00M | 100.00% | 363.10M |
| Q4 FY2019 | 31 Dec 2019 | 2.18B | +201.80% | 73.48% | 2.96B | 100.00% | 1.97B |
| Q3 FY2019 | 30 Sept 2019 | 351.00M | +75.35% | 33.76% | 1.04B | 100.00% | 357.89M |
| Q2 FY2019 | 30 Jun 2019 | 137.17M | +1.57% | 17.72% | 773.91M | 100.00% | 143.93M |
| Q1 FY2019 | 31 Mar 2019 | -26.00M | -108.02% | -4.40% | 591.01M | 100.00% | -19.07M |
| Q4 FY2018 | 31 Dec 2018 | 721.02M | +2.51% | 58.34% | 1.24B | 100.00% | 808.74M |
| Q3 FY2018 | 30 Sept 2018 | 200.17M | +243.35% | 33.44% | 598.60M | 100.00% | 212.06M |
| Q2 FY2018 | 30 Jun 2018 | 135.04M | -74.82% | 26.50% | 509.68M | 100.00% | 146.93M |
| Q1 FY2018 | 31 Mar 2018 | 324.05M | +603.38% | 47.58% | 681.01M | 100.00% | 324.05M |
| Q4 FY2017 | 31 Dec 2017 | 703.39M | -0.63% | 69.10% | 1.02B | 100.00% | 773.14M |
| Q3 FY2017 | 30 Sept 2017 | 58.30M | -68.80% | 18.02% | 323.45M | 100.00% | 68.54M |
| Q2 FY2017 | 30 Jun 2017 | 536.42M | +278.34% | 69.36% | 773.35M | 100.00% | 536.42M |
| Q1 FY2017 | 31 Mar 2017 | 46.07M | +181.96% | 18.37% | 250.78M | 100.00% | 56.31M |
| Q4 FY2016 | 31 Dec 2016 | 707.88M | +88.59% | 76.32% | 927.46M | 100.00% | 826.43M |
| Q3 FY2016 | 30 Sept 2016 | 186.84M | +30.95% | 51.24% | 364.66M | 100.00% | 194.79M |
| Q2 FY2016 | 30 Jun 2016 | 141.78M | +259.70% | 40.07% | 353.83M | 100.00% | 149.74M |
| Q1 FY2016 | 31 Mar 2016 | 16.34M | -90.55% | 9.60% | 170.17M | 100.00% | 16.34M |
| Q4 FY2015 | 31 Dec 2015 | 375.34M | +513.18% | 65.32% | 574.66M | 100.00% | 407.17M |
| Q3 FY2015 | 30 Sept 2015 | 142.68M | +2.41% | 51.37% | 277.77M | 100.00% | 145.76M |
| Q2 FY2015 | 30 Jun 2015 | 39.42M | — | 22.67% | 173.84M | 100.00% | 42.50M |
| Q1 FY2015 | 31 Mar 2015 | 172.94M | +79.49% | 161.96% | 106.78M | 100.00% | -195.25K |
| Q4 FY2014 | 31 Dec 2014 | 61.21M | +14.81% | 28.37% | 215.80M | 100.00% | 73.54M |
| Q3 FY2014 | 30 Sept 2014 | 139.32M | +2,864.97% | 51.31% | 271.52M | 100.00% | 142.24M |
| Q2 FY2014 | 30 Jun 2014 | -31.71M | — | -27.34% | 115.99M | 100.00% | -28.79M |
| Q1 FY2014 | 31 Mar 2014 | 96.35M | +231.03% | 39.00% | 247.07M | 100.00% | 99.27M |
| Q4 FY2013 | 31 Dec 2013 | 53.32M | — | 24.68% | 216.04M | 100.00% | 64.98M |
| Q3 FY2013 | 30 Sept 2013 | 4.70M | — | 3.14% | 149.66M | 100.00% | 8.48M |
| Q2 FY2013 | 30 Jun 2013 | -17.87M | — | -12.94% | 138.09M | 100.00% | -14.09M |
| Q1 FY2013 | 31 Mar 2013 | 29.11M | — | 18.22% | 159.78M | 100.00% | 33.82M |
| Q4 FY2012 | 31 Dec 2012 | -7.90M | — | -4.84% | 163.10M | 100.00% | 603.00K |
| Q3 FY2012 | 30 Sept 2012 | -27.26M | — | -23.52% | 115.88M | 100.00% | -22.46M |
| Q2 FY2012 | 30 Jun 2012 | -37.38M | — | -33.48% | -21.15M | -18.95% | -37.38M |
| Q1 FY2012 | 31 Mar 2012 | -44.15M | — | -46.96% | -29.04M | -30.89% | -37.01M |
| Q4 FY2011 | 31 Dec 2011 | -64.35M | — | -69.14% | -49.13M | -52.79% | 21.97M |
| Q3 FY2011 | 30 Sept 2011 | -57.91M | -134.69% | -63.73% | -40.42M | -44.48% | -54.32M |
| Q2 FY2011 | 30 Jun 2011 | -65.44M | — | -78.01% | -47.67M | -56.83% | -61.74M |
| Q1 FY2011 | 31 Mar 2011 | -61.73M | — | -74.26% | -44.36M | -53.36% | -57.61M |
| Q4 FY2010 | 31 Dec 2010 | -87.32M | — | -95.79% | -57.20M | -62.75% | -4.87M |
| Q3 FY2010 | 30 Sept 2010 | 166.94M | — | 77.79% | 193.71M | 90.27% | 172.11M |
| Q2 FY2010 | 30 Jun 2010 | -93.81M | — | -55.25% | -23.26M | -13.70% | -88.06M |
| Q1 FY2010 | 31 Mar 2010 | -146.50M | — | -137.53% | -113.68M | -106.72% | -140.94M |
| Q4 FY2009 | 31 Dec 2009 | -136.81M | — | -70.92% | 192.90M | 100.00% | 57.30M |
| Q3 FY2009 | 30 Sept 2009 | -148.24M | — | -214.76% | -107.91M | -156.32% | -126.67M |
| Q2 FY2009 | 30 Jun 2009 | — | — | — | — | — | — |
| Q1 FY2009 | 31 Mar 2009 | — | — | — | — | — | — |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Genmab A's operating income
Source: Financial Modeling Prep